反応式
Cl.[NH2:2][C@@H:3]1[C:9](=[O:10])[N:8]([CH2:11][C:12]([O:14][CH2:15][C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=2)=[O:13])[C:7]2[CH:22]=[CH:23][CH:24]=[CH:25][C:6]=2[O:5][CH2:4]1.[CH:26]1([CH2:32][CH2:33][C:34](=O)[C:35]([O:37][CH2:38][CH3:39])=[O:36])[CH2:31][CH2:30][CH2:29][CH2:28][CH2:27]1>>[CH2:38]([O:37][C:35]([C@H:34]([NH:2][C@@H:3]1[C:9](=[O:10])[N:8]([CH2:11][C:12]([O:14][CH2:15][C:16]2[CH:17]=[CH:18][CH:19]=[CH:20][CH:21]=2)=[O:13])[C:7]2[CH:22]=[CH:23][CH:24]=[CH:25][C:6]=2[O:5][CH2:4]1)[CH2:33][CH2:32][CH:26]1[CH2:27][CH2:28][CH2:29][CH2:30][CH2:31]1)=[O:36])[CH3:39]参加物
3
実験手順
Benzyl 3(S)-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-5-acetate hydrochloride (1.5 g) and ethyl 4-cyclohexyl-2-oxobutyrate (2.63 g) are subjected to reductive alkylation reaction in a manner similar to that described in Example 16, and the product is purified by silica gel column chromatography (hexane:ethal acetate=5:1-4:1). From the first fraction, 0.4 g of benzyl 3(S)-[1(R)-ethoxycarbonyl-3-cyclohexylpropyl]amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-5-acetate is obtained as a colorless oil.
後処理
- customalkylation reaction in a manner similar to
- customthe product is purified by silica gel column chromatography (hexane:ethal acetate=5:1-4:1)
出典と根拠
- ORDレコード
- ord-1d47cb60aef046698dfdc68ef83e1de5
- 出典データセット
- uspto-grants-1986_05
- 特許番号
- US04591458
関連ノート
読み込み中…